Taboo Perception of Incontinence, Depression and Cancer

Sponsor
Medical University of Vienna (Other)
Overall Status
Completed
CT.gov ID
NCT00939432
Collaborator
(none)
150
1
17
8.8

Study Details

Study Description

Brief Summary

Objective/study hypothesis To evaluate how much of a taboo UI is and how it compares to other medical conditions that may also pose a taboo issue like depression and cancer.

Background Urinary incontinence (UI) is a highly prevalent condition with more than 200 million people worldwide being affected. While physical health does not necessarily have to be impaired much, restriction of social activities leads to isolation, a significant reduction in quality of life and will often bring about subsequent morbidity. Despite its prevalence, many patients suffering from UI go undiagnosed and untreated. Patients often hesitate to report the problem, and health care professionals often do not ask about it. In a study Minassian (2003) estimated that just one in four patients actively seeks medical attention. The reason for this may lie in the shame, embarrassment, and stigma associated with this condition, which in turn pose significant barriers to seeking professional treatment. Although mentioned by many narrative reviews and included in some epidemiological papers on UI, surprisingly we found no data addressing the taboo of UI exclusively. The aim of our study therefore was

Methods/Design A 13-question self-administered questionnaire was developed and face validity tested by 2 of the authors (KH, EH). The anonymous questionnaire contained simple questions on gender and age and then asked yes/no questions on whether test persons knew people with UI, or suspected other people to be incontinent, if they would address this issue with the suspected person, and if they thought that UI was a taboo issue in the society. On a scale from 0 - 10 they were then asked to grade the amount of embarrassment and anxiety if they themselves were incontinent, compared to depression or cancer. A few questions on knowledge of the condition of UI and to whom test persons would turn to in case of UI concluded the short questionnaire, which took about 5 minutes to fill in. A convenience sample of 150 test persons from waiting areas of a teaching hospital and in private practices of general practitioners in Austria agreed to take part in the study, with an additional 10 persons (6.2%) declining after being informed about the subject. Data were analysed with the SPSS 10.0.5 software package using the U-test, Chi-square-test, Yates-correction, Fisher's exact test and Kolmogorov-Smirnov normality test where appropriate.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    150 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Cross-Sectional
    Official Title:
    The Greatest Taboo- Urinary Incontinence, Depression and Cancer
    Study Start Date :
    Nov 1, 2005
    Actual Primary Completion Date :
    Apr 1, 2006
    Actual Study Completion Date :
    Apr 1, 2007

    Arms and Interventions

    Arm Intervention/Treatment
    Gender

    male/female

    Age

    18-100 years

    Educational level

    primary school, secondary school, university

    Outcome Measures

    Primary Outcome Measures

    1. Perception of given medical condition as a taboo issue [single point in time]

    Secondary Outcome Measures

    1. Knowledge of treatment options of incontinence [single point in time]

    2. Knowledge of friends or relatives with incontinence [single point in time]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Subjects older than 18 years willing to take part in study mentally capable to understand and fill in anonymous questionnaire
    Exclusion Criteria:
    • incomplete questionnaire

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Medical University of Vienna Austria Vienna Austria 1090

    Sponsors and Collaborators

    • Medical University of Vienna

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00939432
    Other Study ID Numbers:
    • EK 453/2008
    First Posted:
    Jul 15, 2009
    Last Update Posted:
    Jul 15, 2009
    Last Verified:
    Jul 1, 2009

    Study Results

    No Results Posted as of Jul 15, 2009